The National Foundation for Infectious Diseases (NFID) has submitted public comments for the March 18–19, 2026 meeting of the Advisory Committee on Immunization Practices (ACIP), the federal advisory body that develops vaccine recommendations for the Centers for Disease Control and Prevention (CDC).
ACIP plays a vital role in helping ensure that US families can choose and access vaccines that help protect against preventable infectious diseases. In its comments, NFID urges the committee to maintain rigorous, transparent, evidence-based decision-making as it considers issues related to COVID-19 vaccine safety, Long COVID, and immunization policy.
NFID notes that billions of doses of COVID-19 vaccines have been safely administered worldwide and that evidence continues to show they reduce the risk of severe illness and hospitalization. The comments also highlight the ongoing impact of Long COVID and the role vaccination can play in helping reduce the risk of long-term health complications following infection.
NFID also emphasizes the importance of transparency in the ACIP process, including publishing meeting agendas in advance so public health experts and liaison organizations can provide informed input on policy decisions that affect patients and families.
Read the full NFID comment letter
About the National Foundation for Infectious Diseases
Founded in 1973, the National Foundation for Infectious Diseases (NFID) is a non-profit 501(c)(3) organization dedicated to educating and engaging the public, communities, and healthcare professionals about infectious diseases across the lifespan. NFID has a 4-star rating from Charity Navigator and has earned a Platinum transparency seal from Candid/GuideStar. For more information, and to access trusted science-based resources on immunization for both healthcare professionals and the public, visit www.nfid.org.
Contact: communications@nfid.org